LeonaBio (LONA) Other Working Capital Changes (2019 - 2026)
LeonaBio (LONA) reported Other Working Capital Changes of -$112000.0 for Q1 2026, down 12.0% year-over-year from -$127272.7 in Q1 2025, and down 106.56% on a QoQ basis from $1.7 million in Q4 2025.
LeonaBio (LONA) has 8 years of Other Working Capital Changes data on file, last reported at -$112000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 12.0% year-over-year to -$112000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$71000.0 (up 81.36% YoY) and the FY2025 annual result came in at -$59000.0, up 83.97% from the prior year.
- Other Working Capital Changes retreated to -$112000.0 in Q1 2026 per LONA's latest filing, from $1.7 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.7 million in Q4 2025 and bottomed at -$1.1 million in Q2 2023.
- The 5-year median for Other Working Capital Changes is -$97000.0 (2024), against an average of -$25941.2.
- The widest annual swing landed in 2022, when Other Working Capital Changes tumbled 6252.94%; it then jumped 1860.82% in 2025.
- Tracing LONA's Other Working Capital Changes over 5 years: stood at $197000.0 in 2022, then sank by 228.43% to -$253000.0 in 2023, then jumped by 61.66% to -$97000.0 in 2024, then jumped by 1860.82% to $1.7 million in 2025, then slumped by 106.56% to -$112000.0 in 2026.
- Per Business Quant, the three latest LONA Other Working Capital Changes figures stand at -$112000.0 (Q1 2026), $1.7 million (Q4 2025), and -$603000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -112,000.00 |
| Mar 31, 2026 | -112,000.00 |
| Dec 31, 2025 | 1.71 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Sep 30, 2025 | -603,000.00 |
| Sep 30, 2025 | -603,000.00 |
| Jun 30, 2025 | -1.06 Mn |
| Jun 30, 2025 | -1.06 Mn |
| Mar 31, 2025 | -100,000.00 |
| Mar 31, 2025 | -100,000.00 |
| Dec 31, 2024 | -97,000.00 |
| Dec 31, 2024 | -97,000.00 |
| Sep 30, 2024 | 870,000.00 |
| Sep 30, 2024 | 870,000.00 |
| Jun 30, 2024 | -1.05 Mn |
| Jun 30, 2024 | -1.05 Mn |
| Mar 31, 2024 | -87,000.00 |
| Mar 31, 2024 | -87,000.00 |
| Dec 31, 2023 | -253,000.00 |
| Dec 31, 2023 | -253,000.00 |
| Sep 30, 2023 | 523,000.00 |
| Sep 30, 2023 | 523,000.00 |
| Jun 30, 2023 | -1.13 Mn |
| Jun 30, 2023 | -1.13 Mn |
| Mar 31, 2023 | 970,000.00 |
| Mar 31, 2023 | 970,000.00 |
| Dec 31, 2022 | 197,000.00 |
| Dec 31, 2022 | 197,000.00 |
| Sep 30, 2022 | 937,000.00 |
| Sep 30, 2022 | 937,000.00 |
| Jun 30, 2022 | -1.08 Mn |
| Jun 30, 2022 | -1.08 Mn |
| Mar 31, 2022 | -69,000.00 |
| Mar 31, 2022 | -69,000.00 |
| Dec 31, 2021 | 3.50 Mn |
| Dec 31, 2021 | 3.50 Mn |
| Sep 30, 2021 | -5.52 Mn |
| Sep 30, 2021 | -5.52 Mn |
| Jun 30, 2021 | -17,000.00 |
| Jun 30, 2021 | -17,000.00 |
| Mar 31, 2021 | 382,000.00 |
| Mar 31, 2021 | 382,000.00 |
| Dec 31, 2020 | 6.30 Mn |
| Dec 31, 2020 | 6.30 Mn |
| Sep 30, 2020 | -1.19 Mn |
| Sep 30, 2020 | -1.19 Mn |
| Jun 30, 2020 | 1.15 Mn |
| Jun 30, 2020 | 1.15 Mn |
| Mar 31, 2020 | 57,000.00 |
| Mar 31, 2020 | 57,000.00 |
| Dec 31, 2019 | 39,000.00 |
| Dec 31, 2019 | 39,000.00 |